Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome

https://doi.org/10.1016/S0960-0760(96)00190-2Get rights and content

Abstract

Sjögren's syndrome, an autoimmune disease that occurs primarily in women, causes extensive inflammation and significant dysfunction in the lacrimal gland, and is one of the leading causes of dry eye syndromes throughout the world. Recently, our research has shown that androgen treatment causes a significant suppression of the immunopathological lesions in lacrimal tissues of female mouse models (MRL/Mp-lpr/lpr [MRL/lpr] and NZB/NZW F1 [F1]) of Sjögren's syndrome. To extend these findings, the objective of the present study was to determine whether this androgen-induced anti-inflammatory action may be paralleled by an increase in the functional activity of lacrimal glands in these autoimmune mice. Towards this end, we measured the tear levels of immunoglobulin A (IgA), which originates from lacrimal tissue and whose concentration is known to be diminished in mucosal sites in Sjögren's syndrome. For comparative purposes, we also evaluated whether the administration of other steroid hormones or immunosuppressive agents might duplicate possible androgen effects on the secretory function of lacrimal tissue. Female MRL/lpr and F1, as well as non-autoimmune BALB/c, mice were treated with vehicle, steroids or immunosuppressive compounds for 17 to 54 days after the onset of disease. Lacrimal glands, tears and sera were collected immediately before (pretreatment), or after, therapy and processed for the analysis of either tear IgA (enzyme-linked immunosorbent assay; ELISA) and protein content or the magnitude of lymphocyte infiltration (computer-assisted image analysis). Our findings demonstrated that testosterone treatment stimulated a significant increase in the concentration and total amount of tear IgA, as well as tear protein, compared to levels in pretreatment or placebo controls. This hormone action was reproduced by exposure to a diverse array of “anabolic” and “androgenic” androgen analogues, but not by treatment with estradiol, danazol, cyclosporine A, dexamethasone or cyclophosphamide. In contrast, only dexamethasone increased serum IgA concentrations. Of particular interest is the fact that the androgen control of IgA output by the lacrimal gland appeared to be independent of this steroid's suppression of lymphocyte infiltration in lacrimal tissue. Overall, these results show that androgen therapy enhances the functional activity of the lacrimal gland in mouse models of Sjögren's syndrome.

References (55)

  • L. Danel et al.

    Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines

    Leuk. Res.

    (1985)
  • S.S. Chen et al.

    Transforming growth factor-β1 (TGF-β1) is a bifunctional immune regulator for mucosal IgA responses

    Cell. Immun.

    (1990)
  • D.W. Brann et al.

    Emerging diversities in the mechanism of action of steroid hormones

    Journal of Steroid Biochemisty & Molecular Biology

    (1995)
  • D.A. Sullivan

    Ocular mucosal immunity

  • R.I. Fox

    Sjögren's Syndrome

    Rheum. Dis. Clin. N.A.

    (1992)
  • M.A. Lemp
  • D.A. Sullivan

    Possible mechanisms involved in the reduced tear secretion in Sjögren's syndrome

  • A.C. Vendramini et al.

    Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren's Syndrome

    Invest. Ophthalmol. Vis. Sci.

    (1991)
  • E.H. Sato et al.

    Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice

    Invest. Ophthalmol. Vis. Sci.

    (1992)
  • E.H. Sato et al.

    Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome

    Invest. Ophthalmol. Vis. Sci.

    (1994)
  • F.J. Rocha et al.

    Effect of androgen analogue treatment and androgen withdrawal on lacrimal gland inflammation in a mouse model (MRL/Mp-lpr/lpr) of Sjögren's syndrome

    Reg. Immun.

    (1994)
  • L.A. Wickham et al.

    Measurement of cytokines in the lacrimal gland and tears: analysis of various methods

    Invest. Ophthalmol. Vis. Sci.

    (1996)
  • I. Toda et al.

    Proto-oncogene and Fas antigen mRNA expression in lacrimal glands of the female, MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome

    Invest. Ophthalmol. Vis. Sci.

    (1995)
  • I. Toda et al.

    Gender- and androgen-related influence on the expression of Fas antigen, bcl-2, c-myc, c-myb and p53 mRNA in lacrimal tissues of autoimmune and non-autoimmune mice

    Invest. Ophthalmol. Vis. Sci.

    (1996)
  • D.A. Sullivan et al.

    Aqueous tear deficiency in Sjögren's syndrome: possible causes and potential treatment

  • Cited by (97)

    • Sexual health in women with Sjogren's syndrome: A review

      2023, European Journal of Obstetrics and Gynecology and Reproductive Biology
    • TFOS DEWS II Sex, Gender, and Hormones Report

      2017, Ocular Surface
      Citation Excerpt :

      Acinar and/or ductal epithelial cells, in turn, are thought to be the primary cells involved in the initiation and perpetuation of autoimmune reactivity in Sjögren syndrome [512]. This androgen-epithelial cell interaction may then induce the altered activity of specific genes and proteins in lacrimal tissue (e.g. cytokines, proto-oncogenes and apoptotic factors), leading to the reduction of immunopathological lesions and an improvement in glandular function [348,358,374,375,377,384]. In contrast to the above, some investigators have proposed that androgen insufficiency causes an autoimmune process in the lacrimal gland, leading to inflammation, a Sjögren syndrome-like pathology and aqueous tear deficiency [361,362,513,514].

    • Ocular Mucosal Immunity

      2015, Mucosal Immunology: Fourth Edition
    • Potentially pathogenic immune cells and networks in apparently healthy lacrimal glands

      2015, Ocular Surface
      Citation Excerpt :

      The importance of ongoing, constitutive peripheral immunoregulatory mechanisms is emphasized by the identification of lacrimal epithelial cell internal vesicle trafficking pathways that may constitutively release autoantigens to the lacrimal gland's stromal spaces.29 Androgen therapy has proven highly beneficial in some murine models of inflammatory lacrimal gland diseases,30 and a preliminary case review study has suggested that androgen supplementation of estrogen-progestin replacement therapy ameliorates signs and symptoms in women with severe dry eye disease.31 Studies have found a number of intriguing clues into how the lacrimal epithelia function as a nexus between hormonal status and local immunological activity; nonetheless, this nexus has remained largely a black box, slow to yield insights into its inner workings.

    • Sjögren's Syndrome

      2013, Women and Health
    View all citing articles on Scopus
    View full text